DE3689767D1 - Immunverstärker und verwandte Zusammensetzungen. - Google Patents

Immunverstärker und verwandte Zusammensetzungen.

Info

Publication number
DE3689767D1
DE3689767D1 DE86118104T DE3689767T DE3689767D1 DE 3689767 D1 DE3689767 D1 DE 3689767D1 DE 86118104 T DE86118104 T DE 86118104T DE 3689767 T DE3689767 T DE 3689767T DE 3689767 D1 DE3689767 D1 DE 3689767D1
Authority
DE
Germany
Prior art keywords
related compositions
immune boosters
boosters
immune
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE86118104T
Other languages
English (en)
Other versions
DE3689767T2 (de
Inventor
Arthur A Gottlieb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/813,632 external-priority patent/US4699898A/en
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3689767D1 publication Critical patent/DE3689767D1/de
Publication of DE3689767T2 publication Critical patent/DE3689767T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/12—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE3689767T 1985-12-26 1986-12-29 Immunverstärker und verwandte Zusammensetzungen. Expired - Lifetime DE3689767T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/813,632 US4699898A (en) 1985-12-26 1985-12-26 Tripeptides affecting immune response
US90268386A 1986-09-02 1986-09-02

Publications (2)

Publication Number Publication Date
DE3689767D1 true DE3689767D1 (de) 1994-05-11
DE3689767T2 DE3689767T2 (de) 1994-08-25

Family

ID=27123762

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3689767T Expired - Lifetime DE3689767T2 (de) 1985-12-26 1986-12-29 Immunverstärker und verwandte Zusammensetzungen.

Country Status (9)

Country Link
EP (1) EP0230052B1 (de)
JP (1) JP2502553B2 (de)
AU (1) AU619441B2 (de)
CA (1) CA1286989C (de)
DE (1) DE3689767T2 (de)
DK (1) DK612786A (de)
FI (1) FI865267A (de)
IL (1) IL81072A0 (de)
NO (1) NO865302L (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3782958D1 (de) * 1986-02-19 1993-01-21 Imreg Inc Verfahren und mittel zum pruefen eines immunsystems.
US4880779A (en) * 1987-07-31 1989-11-14 Research Corporation Technologies, Inc. Method of prevention or treatment of AIDS by inhibition of human immunodeficiency virus
CA1340588C (en) * 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
GB8927913D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Amino acid derivatives
DE4303530C2 (de) * 1993-02-06 1997-04-03 Milan C Dr Med Pesic Pharmazeutische Verwendung eines Enkephalins
RU2107692C1 (ru) 1995-06-07 1998-03-27 Дейгин Владислав Исакович Пептид и способ его получения
RU2107691C1 (ru) 1995-03-02 1998-03-27 Дейгин Владислав Исакович Пептид и способ его получения
US7632818B2 (en) * 2003-03-20 2009-12-15 Gottlieb Marise S Method for treating conditions associated with the Metabolic Syndrome (Syndrome X)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE53572B1 (en) * 1980-05-14 1988-12-21 Arthur Gottlieb A Modulators of the immune system
US4468379A (en) * 1982-05-06 1984-08-28 Endeavor Corp. Leukocyte extracts for affecting the immune system
DK134784A (da) * 1983-03-07 1984-09-08 Lilly Co Eli Farmakologisk virksomme tripeptid-derivater og fremgangsmaade til fremstilling deraf
US4599325A (en) * 1984-02-16 1986-07-08 G. D. Searle & Co. Substituted tyrosyl alanine dipeptide amides
US4616079A (en) 1984-08-24 1986-10-07 Imreg, Inc. Immunoamplifiers and processes for the extraction thereof
US4710380A (en) 1986-04-04 1987-12-01 Imreg, Inc. Treatment of autoimmune disorders with immunoamplifiers

Also Published As

Publication number Publication date
JP2502553B2 (ja) 1996-05-29
AU6697086A (en) 1987-07-02
FI865267A0 (fi) 1986-12-22
NO865302D0 (no) 1986-12-23
JPS62228023A (ja) 1987-10-06
EP0230052A2 (de) 1987-07-29
AU619441B2 (en) 1992-01-30
FI865267A (fi) 1987-06-27
DK612786A (da) 1987-06-27
IL81072A0 (en) 1987-03-31
DK612786D0 (da) 1986-12-18
EP0230052B1 (de) 1994-04-06
DE3689767T2 (de) 1994-08-25
CA1286989C (en) 1991-07-30
EP0230052A3 (en) 1989-08-30
NO865302L (no) 1987-06-29

Similar Documents

Publication Publication Date Title
DE3677479D1 (de) Fettzusammensetzung.
DE3685409D1 (de) Antitumorzusammensetzung.
FI865037A0 (fi) Mikrobicida kompositioner.
FI862094A0 (fi) Bornerande terapeutisk komposition.
DE3684564D1 (de) Veterinaere zusammensetzungen.
ES2019061B3 (es) Composicion quimiluminiscente.
DE3679103D1 (de) Haertbare organopolysiloxanzusammensetzungen.
DE3681140D1 (de) Polyaethylenzusammensetzung.
DE3875300T2 (de) Turbo-verbundmaschine.
DE3684003D1 (de) Propylen-polymer-zusammensetzung.
DE3684626D1 (de) Schmerzstillende zusammensetzung.
DE3583866D1 (de) Kompositmasse.
DE3686698T2 (de) Futterzusammensetzung.
DE3669105D1 (de) Therapeutische zusammensetzung.
DE3671446D1 (de) 5-aralkylsubstituierte 2h-benztriazole und stabilisierte zusammensetzungen.
DE3686740D1 (de) Einkomponenthaertbare zusammensetzung.
NL190241C (nl) Thermoplastische samenstellingen en daarop gebaseerde voortbrengselen.
IT1213453B (it) Composizione farmaceutica.
DE3675851D1 (de) Phthalimidoester enthaltende polyesterzusammensetzungen.
DE3689767T2 (de) Immunverstärker und verwandte Zusammensetzungen.
DK139886A (da) Vandig tekstilbehandlingskomposition
GB2177916B (en) Coametic compositions.
DE3669656D1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.
FI873270A0 (fi) De-(acetylglukosaminyl)-di(dehydro) -deoxi-teikoplaninderivat.
DK86785A (da) Bromcryptinpraeparater

Legal Events

Date Code Title Description
8364 No opposition during term of opposition